Antifibrotic effect of MMP13-encoding plasmid DNA delivered using polyethylenimine shielded with hyaluronic acid

Molecular Therapy

Volumn 19, Issue 2, 2011, Pages 355-361

  Kim, Eun Joong ^a   Cho, Hee Jeong ^a   Park, Daeui ^b   Kim, Ji Yeon ^b   Kim, Young Bong ^c   Park, Tae Gwan ^d   Shim, Chang Koo ^a   Oh, Yu Kyoung ^a  

^a Seoul National University   (South Korea)

^b Korea University   (South Korea)

^c Konkuk University   (South Korea)

^d Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CALCIUM CHLORIDE; COLLAGENASE 3; COMPLEMENTARY DNA; ENHANCED GREEN FLUORESCENT PROTEIN; HYALURONIC ACID; MESSENGER RNA; PLASMID DNA; POLYETHYLENEIMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL VIABILITY; COLLAGEN SYNTHESIS; COMPLEX FORMATION; CONTROLLED STUDY; DNA SEQUENCE; DRUG DOSE ESCALATION; DRUG MECHANISM; ENZYME STABILITY; HISTOPATHOLOGY; IMMUNOBLOTTING; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; LIVER FIBROSIS; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; ZETA POTENTIAL;

MUS;

EID: 79551615156     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.262     Document Type: Article

References (30)

1. Bataller, R and Brenner, DA (2005). Liver fibrosis. J Clin Invest 115: 209-218.
2. Sakaida, I, Hironaka, K, Uchida, K, Suzuki, C, Kayano, K and Okita, K (1998). Fibrosis accelerates the development of enzyme-altered lesions in the rat liver. Hepatology 28: 1247-1252.
3. Popov, Y and Schuppan, D (2009). Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 50: 1294-1306.
4. Rockey, DC (2008). Current and future anti-fibrotic therapies for chronic liver disease. Clin Liver Dis 12: 939-62, xi.
5. Friedman, SL (2003). Liver fibrosis - from bench to bedside. J Hepatol 38 Suppl 1: S38-S53.
6. Hemmann, S, Graf, J, Roderfeld, M and Roeb, E (2007). Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 46: 955-975.
7. Yan, S, Chen, GM, Yu, CH, Zhu, GF, Li, YM and Zheng, SS (2005). Expression pattern of matrix metalloproteinases-13 in a rat model of alcoholic liver fibrosis. HBPD INT 4: 569-572.
8. Watanabe, T, Niioka, M, Hozawa, S, Kameyama, K, Hayashi, T, Arai, M et al. (2000). Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride. J Hepatol 33: 224-235.
9. Muddu, AK, Guha, IN, Elsharkawy, AM and Mann, DA (2007). Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic. Int J Biochem Cell Biol 39: 695-714.
10. Iimuro, Y and Brenner, DA (2008). Matrix metalloproteinase gene delivery for liver fibrosis. Pharm Res 25: 249-258.
11. Iimuro, Y, Nishio, T, Morimoto, T, Nitta, T, Stefanovic, B, Choi, SK et al. (2003). Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology 124: 445-458.
12. Siller-López, F, Sandoval, A, Salgado, S, Salazar, A, Bueno, M, Garcia, J et al. (2004). Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis. Gastroenterology 126: 1122-33; discussion 949.
13. Seow, Y and Wood, MJ (2009). Biological gene delivery vehicles: beyond viral vectors. Mol Ther 17: 767-777.
14. Park, TG, Jeong, JH and Kim, SW (2006). Current status of polymeric gene delivery systems. Adv Drug Deliv Rev 58: 467-486.
15. Lungwitz, U, Breunig, M, Blunk, T and Göpferich, A (2005). Polyethylenimine-based non-viral gene delivery systems. Eur J Pharm Biopharm 60: 247-266.
16. Oh, YK, Kim, JP, Yoon, H, Kim, JM, Yang, JS and Kim, CK (2001). Prolonged organ retention and safety of plasmid DNA administered in polyethylenimine complexes. Gene Ther 8: 1587-1592.
17. Hunter, AC (2006). Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity. Adv Drug Deliv Rev 58: 1523-1531.
18. Hornof, M, de la Fuente, M, Hallikainen, M, Tammi, RH and Urtti, A (2008). Low molecular weight hyaluronan shielding of DNA/PEI polyplexes facilitates CD44 receptor mediated uptake in human corneal epithelial cells. J Gene Med 10: 70-80.
19. Surace, C, Arpicco, S, Dufaÿ-Wojcicki, A, Marsaud, V, Bouclier, C, Clay, D et al. (2009). Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells. Mol Pharm 6: 1062-1073.
20. Kim, EJ, Shim, G, Kim, K, Kwon, IC, Oh, YK and Shim, CK (2009). Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs. J Gene Med 11: 791-803.
21. Jiang, G, Park, K, Kim, J, Kim, KS and Hahn, SK (2009). Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis. Mol Pharm 6: 727-737.
22. Oh, EJ, Park, K, Kim, KS, Kim, J, Yang, JA, Kong, JH et al. (2010). Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. J Control Release 141: 2-12.
23. Moghimi, SM, Symonds, P, Murray, JC, Hunter, AC, Debska, G and Szewczyk, A (2005). A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol Ther 11: 990-995.
24. Ogris, M, Brunner, S, Schüller, S, Kircheis, R and Wagner, E (1999). PEGylated DNA/ transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 6: 595-605.
25. Kyosseva, SV, Harris, EN and Weigel, PH (2008). The hyaluronan receptor for endocytosis mediates hyaluronan-dependent signal transduction via extracellular signal-regulated kinases. J Biol Chem 283: 15047-15055.
26. Harris, EN, Weigel, JA and Weigel, PH (2008). The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparin. J Biol Chem 283: 17341-17350.
27. Yang, CM, Hsieh, HL, Yao, CC, Hsiao, LD, Tseng, CP and Wu, CB (2009). Protein kinase C-delta transactivates platelet-derived growth factor receptor-alpha in mechanical strain-induced collagenase 3 (matrix metalloproteinase-13) expression by osteoblast-like cells. J Biol Chem 284: 26040-26050.
28. Hu, PF, Chen, H, Zhong, W, Lin, Y, Zhang, X, Chen, YX et al. (2009). Adenovirusmediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats. J Hepatol 51: 102-113.
29. Xu, R, Harrison, PM, Chen, M, Li, L, Tsui, TY, Fung, PC et al. (2006). Cytoglobin overexpression protects against damage-induced fibrosis. Mol Ther 13: 1093-1100.
30. Schievenbusch, S, Strack, I, Scheffler, M, Nischt, R, Coutelle, O, Hösel, M et al. (2010). Combined paracrine and endocrine AAV9 mediated expression of hepatocyte growth factor for the treatment of renal fibrosis. Mol Ther 18: 1302-1309.